Zimmer Biomet To Present At The 43Rd Annual J.P. Morgan Healthcare Conference


(MENAFN- PR Newswire)

WARSAW, Ind., Dec. 20, 2024 /PRNewswire/ --
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the 43rd Annual J.P. Morgan Healthcare conference on Tuesday, January 14, 2025, at 8:15 a.m. PT (11:15 a.m. ET).

A live webcast of the presentation can be accessed via Zimmer Biomet's Investor Relations website at . The webcast will be archived for replay following the conference.

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit

or follow on LinkedIn at

or X / Twitter at

Media

Investors

Heather Zoumas-Lubeski

David DeMartino

(445) 248-0577

(646) 531-6115

[email protected]

[email protected]


Zach Weiner


(908) 591-6955


[email protected]

SOURCE Zimmer Biomet Holdings, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN20122024003732001241ID1109016492


PR Newswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.